AGP Executive Report
Last update: 4 hours agoFlu Watch: Taiwan’s CDC says flu-like outpatient and emergency visits hit 101,628 last week, pushing the island toward a seasonal influenza epidemic period in the next 1–2 weeks; influenza A(H1N1) is dominant, and severe cases are rising as emergency visits near the 11% threshold. Rare Cancer Breakthrough: The FDA approved PharmaEssentia’s BESREMi (ropeginterferon alfa-2b-njft) for adults with essential thrombocythemia, the first new treatment for the rare blood cancer in nearly 30 years, aiming for durable disease control beyond just platelet lowering. Hospital Fraud Probe: Kaohsiung prosecutors indicted a weight-loss doctor accused of defrauding 424 patients of about NT$18.02 million by billing for a surgical device allegedly never used. Health Security & Drugs: Australia is set to announce a $600 million Pacific plan to curb drug smuggling, including more aerial surveillance and regional police training, as illicit trafficking fuels serious health harms. Trade Compliance: A Taiwan-based LED maker agreed to pay $5.15 million in the U.S. to resolve allegations of misrepresenting LED origin to avoid tariffs. AI Infrastructure in Taiwan: Microsoft says its Taiwan Azure region is operating for select customers and is expanding toward broader availability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
